Muzamil Amin Chisti Yousef Binamer Abdullah Alfadley Abdulmonem Almutawa
10.5144/0256-4947.2019.56
Ann Saudi Med
2019 Jan-Feb;39(1):56-60.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/30712052/
Acitretin / therapeutic use Keratolytic Agents / therapeutic use Penicillamine / adverse effects Pseudoxanthoma Elasticum / drug therapy Skin Diseases / drug therapy
Acitretin / therapeutic use Keratolytic Agents / therapeutic use Penicillamine / adverse effects Pseudoxanthoma Elasticum / drug therapy Skin Diseases / drug therapy Case Reports Adult Hepatolenticular Degeneration / drug therapy Humans Male Pseudoxanthoma Elasticum / chemically induced Skin Diseases / chemically induced Treatment Outcome Keratolytic Agents Penicillamine Acitretin Elastosis perforans serpiginosa
PMC6464679
30712052
D-penicillamine-induced pseudo-pseudoxanthoma elasticum and extensive elastosis perforans serpiginosa with excellent response to acitretin
2019